P

Inventor

LIOTTA DENNIS C

US107 patents
⚠️ This page may combine multiple inventors who share the name “LIOTTA DENNIS C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV EMORY

43 patents
US6232300B1May 15, 2001

Treatment of HIV by administration of β-D-2′, 3′-didehydro-2′,3′-dideoxy-5-fluorocytidine (D4FC)

UNIV EMORY87 citations99
US5914331AJun 22, 1999

Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane

UNIV EMORY113 citations99
US5905070AMay 18, 1999

5--Caboxamido or 5--fluoro!-- 2', 3'--unsaturated or 3'--modified!--pyrimidine nucleosides

UNIV EMORY98 citations99
US5814639ASep 29, 1998

Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds

UNIV EMORY139 citations99
US5703058ADec 30, 1997

Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent

UNIV EMORY124 citations99
US5539116AJul 23, 1996

Method and compositions for the synthesis of BCH-189 and related compounds

UNIV EMORY137 citations99
US5210085AMay 11, 1993

Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds

UNIV EMORY178 citations99
US5204466AApr 20, 1993

Method and compositions for the synthesis of bch-189 and related compounds

UNIV EMORY134 citations99
US7307065B2Dec 11, 2007

2′-Fluoronucleosides

UNIV EMORY118 citations98
US6911424B2Jun 28, 2005

2′-fluoronucleosides

UNIV EMORY174 citations98
US6348587B1Feb 19, 2002

2′-Fluoronucleosides

UNIV EMORY296 citations98
US7662938B2Feb 16, 2010

2′-fluoronucleosides

UNIV EMORY31 citations96
US6703396B1Mar 9, 2004

Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers

UNIV EMORY64 citations96
US6680303B2Jan 20, 2004

3′,5-difluoro-2′,3′-didehydropyrimidine nucleosides and methods of treatment therewith

UNIV EMORY54 citations96
US6642245B1Nov 4, 2003

Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane

UNIV EMORY65 citations96
US6391859B1May 21, 2002

[5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides

UNIV EMORY61 citations96
US5914400AJun 22, 1999

Method and compositions for the synthesis of BCH-189 and related compounds

UNIV EMORY29 citations96
US5892025AApr 6, 1999

Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers

UNIV EMORY45 citations96
US5827727AOct 27, 1998

Method of resolution of 1,3-oxathiolane nucleoside enantiomers

UNIV EMORY44 citations96
US5728575AMar 17, 1998

Method of resolution of 1,3-oxathiolane nucleoside enantiomers

UNIV EMORY48 citations96
US5276151AJan 4, 1994

Method of synthesis of 1,3-dioxolane nucleosides

UNIV EMORY63 citations96
US6664272B2Dec 16, 2003

Curcumin analogs with anti-tumor and anti-angiogenic properties

UNIV EMORY50 citations95
US5872107AFeb 16, 1999

Treatment of urogenital cancer with boron neutron capture therapy

UNIV EMORY45 citations95
US5599796AFeb 4, 1997

Treatment of urogenital cancer with boron neutron capture therapy

UNIV EMORY78 citations95
US6777441B2Aug 17, 2004

Triptolide analogs for the treatment of autoimmune and inflammatory disorders

UNIV EMORY50 citations94
US6610835B1Aug 26, 2003

Sphingolipid derivatives and their methods of use

UNIV EMORY98 citations94
US6346627B1Feb 12, 2002

Intermediates in the synthesis of 1,3-oxathiolane nucleoside enantiomers

UNIV EMORY14 citations93
US6114343ASep 5, 2000

Antiviral activity and resolution of 2-hydroxymethyl-5-(5-flurocytosin-1-yl)-1,3-oxathiolane

UNIV EMORY17 citations93
US6069252AMay 30, 2000

Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers

UNIV EMORY22 citations93
US5852027ADec 22, 1998

Antiviral 1,3-dioxolane nucleoside analogues

UNIV EMORY21 citations93
US5700937ADec 23, 1997

Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds

UNIV EMORY43 citations93
US7495006B2Feb 24, 2009

2′ and 3′-substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation

UNIV EMORY36 citations91
US8008312B2Aug 30, 2011

CXCR4 antagonists for the treatment of HIV infection

UNIV EMORY17 citations90
US7635690B2Dec 22, 2009

HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine

UNIV EMORY23 citations90
US5232837AAug 3, 1993

Method of altering sphingolipid metabolism and detecting fumonisin ingestion and contamination

UNIV EMORY21 citations90
US6153596ANov 28, 2000

Polycationic oligomers

UNIV EMORY46 citations88
US10149859B2Dec 11, 2018

Nucleotide and nucleoside therapeutic compositions and uses related thereto

UNIV EMORY6 citations83
US10016408B2Jul 10, 2018

Chemokine CXCR4 receptor modulators and uses related thereto

UNIV EMORY4 citations83
US9545403B2Jan 17, 2017

Chemokine CXCR4 receptor modulators and uses related thereto

UNIV EMORY6 citations83
US7371766B2May 13, 2008

Curcumin analogs with anti-tumor and anti-angiogenic properties

UNIV EMORY11 citations83
US10487109B2Nov 26, 2019

Progesterone phosphate analogs and uses related thereto

UNIV EMORY5 citations82
US9802978B2Oct 31, 2017

Progesterone phosphate analogs and uses related thereto

UNIV EMORY5 citations82
US6215004B1Apr 10, 2001

Method of manufacture of 1,3-oxathiolane nucleosides

UNIV EMORY13 citations80

SCHINAZI RAYMOND F

2 patents

(unassigned)

1 patent

LIOTTA DENNIS C

1 patent

TRAYNELIS STEPHEN F

1 patent

WILSON LAWRENCE J

1 patent

MACNEVIN CHRISTOPHER

1 patent

Showing the top 50 of 107 patents by PatentIndex Score.